Using the Star Forming Main Sequence To Explore Quiescent Galaxies Across Cosmic Time
Authors:
Tyler Houston,
Darren J. Croton,
Manodeep Sinha
Abstract:
In this letter, we explore the quiescent lives of central galaxies using the SAGE galaxy model and Uchuu dark matter simulation. We ask three questions: (1) How much of a galaxy's life is spent in quiescence? (2) How often do galaxies transition off the main sequence? (3) What is the typical duration of a quiescent phase? We find low and high-mass galaxies spend the highest fraction of their lives…
▽ More
In this letter, we explore the quiescent lives of central galaxies using the SAGE galaxy model and Uchuu dark matter simulation. We ask three questions: (1) How much of a galaxy's life is spent in quiescence? (2) How often do galaxies transition off the main sequence? (3) What is the typical duration of a quiescent phase? We find low and high-mass galaxies spend the highest fraction of their lives in quiescence: 45 \pm 19% for log10(Mstar) < 9.0 (3.68 \pm 1.80 Gyr) and 26 \pm 25% for log10(Mstar) > 11.5 (3.46 \pm 3.30 Gyr), falling to 7 \pm 13% for galaxies in-between (0.82 \pm 1.57 Gyr). Low mass galaxies move in and out of quiescence frequently, 2.8 \pm 1.3 times on average, though only for short periods, 1.49 \pm 1.04 Gyr. This can be traced to the influence of supernova feedback on their quite stochastic evolution. Galaxies of higher mass have fewer quiescent periods, ~0.7 \pm 0.9, and their length increases with mass, peaking at 1.97 \pm 2.27 Gyr. However, our high-mass population comprises star-forming and quiescent galaxies with diverging evolutionary paths, so the actual time may be even longer. These high-mass trends are driven by radio mode feedback from supermassive black holes, which, once active, tend to remain active for extended periods.
△ Less
Submitted 13 March, 2023;
originally announced March 2023.
A Review of Mathematical Models for Muscular Dystrophy: A Systems Biology Approach
Authors:
Amanda N. Cameron,
Matthew T. Houston,
Juan B. Gutierrez
Abstract:
Muscular dystrophy (MD) describes generalized progressive muscular weakness due to the wasting of muscle fibers. The progression of the disease is affected by known immunological and mechanical factors, and possibly other unknown mechanisms. These dynamics have begun to be elucidated in the last two decades. This article reviews mathematical models of MD that characterize molecular and cellular co…
▽ More
Muscular dystrophy (MD) describes generalized progressive muscular weakness due to the wasting of muscle fibers. The progression of the disease is affected by known immunological and mechanical factors, and possibly other unknown mechanisms. These dynamics have begun to be elucidated in the last two decades. This article reviews mathematical models of MD that characterize molecular and cellular components implicated in MD progression. A biological background for these processes is also presented. Molecular effectors that contribute to MD include mitochondrial bioenergetics and genetic factors; both drive cellular metabolism, communication and signaling. These molecular events leave cells vulnerable to mechanical stress which can activate an immunological cascade that weakens cells and surrounding tissues. This review article lays the foundation for a systems biology approach to study MD progression.
△ Less
Submitted 28 October, 2016; v1 submitted 11 October, 2016;
originally announced October 2016.
